Sonoma Pharmaceuticals, Inc. balance sheet

At the end of fiscal 2026, Sonoma Pharmaceuticals, Inc. had total assets of $14.0m, total liabilities of $10.9m and shareholders' equity of $3.1m. It held $2.4m in cash against $222,000 of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Sonoma Pharmaceuticals, Inc.: balance sheet, annual
Fiscal year	2011Mar 2011	2012Mar 2012	2013Mar 2013	2014Mar 2014	2015Mar 2015	2016Mar 2016	2017Mar 2017	2018Mar 2018	2019Mar 2019	2020Mar 2020	2021Mar 2021	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026	LTMJun 2026
Cash and equivalents	4	3	8	5	6	7	17	10	4	4	4	7	4	3	5	2	5
Receivables	2	2	2	2	2	2	2	2	3	4	3	2	3	3	2	3	3
Inventory	1	1	1	1	1	2	2	3	3	2	3	3	3	3	3	4	4
Total current assets	8	7	12	10	10	13	23	16	12	12	13	16	14	13	13	12	16
Total assets	9	8	13	21	15	14	25	19	14	15	15	19	16	15	14	14	18
Accounts payable	1	1	1	1	1	1	1	1	1	2	2	2	1	1	1	2	2
Deferred revenue (current)	2	2	2	3	1	0	0	0	0	0	0	1	0	0	1	0	0
Total current liabilities	4	5	5	8	3	4	3	3	4	5	4	6	4	4	4	5	5
Short-term debt	1	1	1	0	0	0	0	0	0	0	1	—	0	0	0	0	0
Long-term debt	2	2	1	0	0	0	0	0	0	0	1	0	—	—	—	—	—
Total debt	3	3	3	0	0	0	0	0	0	0	2	0	0	0	0	0	0
Total liabilities	7	9	8	9	3	4	4	4	4	9	10	10	8	9	9	11	12
Shareholders' equity	2	−1	4	12	12	10	21	15	8	6	5	9	8	6	4	3	7
Non-controlling interests and other (assets − liabilities − equity)	—	—	—	—	—	—	—	—	3	—	—	—	—	—	—	—	—
Shares outstanding	27m	—	7m	8m	—	17m	—	—	—	—	—	—	—	—	—	2m	—

US$ millions unless shown otherwise. Fiscal quarters.

Sonoma Pharmaceuticals, Inc.: balance sheet, quarterly
Quarter	2025 Q2Sept 2024	2025 Q3Dec 2024	2025 Q4Mar 2025	2026 Q1Jun 2025	2026 Q2Sept 2025	2026 Q3Dec 2025	2026 Q4Mar 2026	2027 Q1Jun 2026
Receivables	3	2	2	3	3	2	3	3
Inventory	3	3	3	4	4	4	4	4
Total current assets	12	12	13	13	13	12	12	16
Total assets	14	14	14	15	14	14	14	18
Accounts payable	1	1	1	2	1	2	2	2
Deferred revenue (current)	0	0	1	1	1	0	0	0
Total current liabilities	3	4	4	5	4	4	5	5
Short-term debt	0	0	0	0	0	0	0	0
Total debt	0	0	0	0	0	0	0	0
Total liabilities	8	9	9	11	10	10	11	12
Shareholders' equity	5	5	4	4	4	3	3	7
Shares outstanding	1m	2m	2m	2m	2m	2m	2m	5m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: BDMD vs SNOA SNOA vs VVOS NEPH vs SNOA SNOA vs ZJYL

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Sonoma Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Sonoma Pharmaceuticals, Inc.